Related Experiment Video

Updated: Aug 8, 2026

Fluorescence-based Monitoring of PAD4 Activity via a Pro-fluorescence Substrate Analog
08:37

Fluorescence-based Monitoring of PAD4 Activity via a Pro-fluorescence Substrate Analog

Published on: November 5, 2014

Restricted expression of tumor necrosis factor-related apoptosis-inducing ligand receptor 4 in human peripheral blood

Hiroo Hasegawa1, Yasuaki Yamada, Hitomi Harasawa

  • 1Department of Laboratory Medicine, Nagasaki University Graduate School of Biomedical Sciences, Nagasaki, Japan.

Cellular Immunology
|May 28, 2005
PubMed

Insights

Tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) receptors show specific expression patterns on normal immune cells. Understanding these TRAIL receptor distributions is key for developing targeted cancer therapies.

Area of Science:

  • Immunology
  • Molecular Biology
  • Cancer Therapeutics

Background:

  • Tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) induces apoptosis in cancer cells, offering therapeutic potential.
  • The distribution and modulation of TRAIL receptors in normal cells remain incompletely understood.
  • Characterizing TRAIL receptor expression is crucial for assessing therapeutic safety and efficacy.

Purpose of the Study:

  • To investigate the cell surface expression patterns of TRAIL receptors in normal human peripheral blood.
  • To identify specific immune cell populations expressing different TRAIL receptors.
  • To provide insights into the potential for TRAIL-based cancer therapies.

Main Methods:

  • Analysis of cell surface expression of TRAIL receptors (TRAIL-R1, TRAIL-R2, TRAIL-R3, TRAIL-R4).
  • Utilized peripheral blood from normal healthy donors.
  • Characterized receptor expression on distinct immune cell subsets.

Main Results:

  • TRAIL receptors exhibit restricted expression on specific immune cell types.
  • TRAIL-R1 was predominantly found on B-lymphocytes.
  • TRAIL-R2 expression was observed on monocytes, TRAIL-R3 on neutrophils.
  • TRAIL-R4 was notably expressed on CD8+ lymphocytes and NKT lymphocytes, but not CD4+ lymphocytes.

Conclusions:

  • TRAIL receptor expression is highly specific across different normal immune cell populations.
  • This differential expression provides a basis for understanding TRAIL's selective action on tumor cells.
  • Findings support the potential for targeted TRAIL-based cancer treatments with reduced side effects on normal tissues.

More Related Videos

A Novel Feeder-free System for Mass Production of Murine Natural Killer Cells In Vitro10:36

A Novel Feeder-free System for Mass Production of Murine Natural Killer Cells In Vitro

Published on: January 9, 2018

Isolation of CD4+ T-cells and Analysis of Circulating T-follicular Helper (cTfh) Cell Subsets from Peripheral Blood Using 6-color Flow Cytometry07:39

Isolation of CD4+ T-cells and Analysis of Circulating T-follicular Helper (cTfh) Cell Subsets from Peripheral Blood Using 6-color Flow Cytometry

Published on: January 7, 2019

Related Concept Videos

Receptor Downregulation in MVBs01:15

Receptor Downregulation in MVBs

Multivesicular bodies (MVBs) are mature endosomes that sort ubiquitinated proteins and then fuse with lysosomes to degrade the sorted proteins. Epidermal growth factor (EGF) and its receptor (EGFR) form a complex that can be internalized through endocytosis, sorted into an MVB, and later degraded.
The EGFR can initiate signaling pathways that  lead to cell proliferation, migration, and differentiation. Overexpression of EGFR  stimulates cells to proliferate. Excessive  EGFR activation may...
The Extrinsic Apoptotic Pathway01:17

The Extrinsic Apoptotic Pathway

The extrinsic apoptotic pathway is initiated when extracellular death-inducing signals, such as specific cytokines, activate the death receptors expressed on the cell surface. The immune cells involved in this pathway are natural killer cells (NK cells) and cytotoxic T-lymphocytes. NK cells are critical in innate immune response, while cytotoxic T-lymphocytes are associated with adaptive immune response. These cells recognize specific receptors expressed on the altered cells and activate...